MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000330950

Медицинская библиотека · Acta haematologica · 2011

Successful treatment of chemotherapy-refractory angioimmunoblastic T cell lymphoma with cyclosporin A.

Kobayashi Tsutomu, Kuroda Junya, Uchiyama Hitoji, Matsumoto Yosuke, Horiike Shigeo, Taniwaki Masafumi

Клинический случайСтатьяПеревод в очереди

Аннотация

Angioimmunoblastic T cell lymphoma (AITL) is a rare subtype of T cell non-Hodgkin lymphoma. The standard therapeutic strategy for AITL has not yet been established, and its prognosis remains poor. This report concerns the effect of cyclosporin A (CsA) on chemotherapy-refractory AITL. A 68-year-old female with AITL with systemic symptoms, such as high fever, skin rash and generalized lymphadenopathy, was initially treated with conventional cytotoxic chemotherapies using alkylators, anthracyclines and corticosteroids, which failed to induce remission. However, CsA (4 mg/kg/day) plus dexamethasone treatment resulted in a dramatic regression of the tumors and amelioration of systemic symptoms and induced complete remission (CR) within 2 weeks. Currently, the patient's CR has continued for more than 18 months with CsA maintenance therapy. Our experience and previously reported findings suggest that CsA may constitute an alternative treatment option for AITL, even though the use of conventional cytotoxic chemotherapy continues to be the first-line therapy on an empirical basis.

Для цитирования: Kobayashi Tsutomu, Kuroda Junya, Uchiyama Hitoji, Matsumoto Yosuke, Horiike Shigeo, Taniwaki Masafumi. Successful treatment of chemotherapy-refractory angioimmunoblastic T cell lymphoma with cyclosporin A.. Acta haematologica. 2011. DOI: 10.1159/000330950.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.